1: Oliver RA, Li R, Townsend CA. Monobactam formation in sulfazecin by a nonribosomal peptide synthetase thioesterase. Nat Chem Biol. 2018 Jan;14(1):5-7. doi: 10.1038/nchembio.2526. Epub 2017 Nov 20. PubMed PMID: 29155429; PubMed Central PMCID: PMC5726899.
2: Horsman ME, Marous DR, Li R, Oliver RA, Byun B, Emrich SJ, Boggess B, Townsend CA, Mobashery S. Whole-Genome Shotgun Sequencing of Two β-Proteobacterial Species in Search of the Bulgecin Biosynthetic Cluster. ACS Chem Biol. 2017 Oct 20;12(10):2552-2557. doi: 10.1021/acschembio.7b00687. Epub 2017 Sep 26. PubMed PMID: 28937735; PubMed Central PMCID: PMC5653948.
3: Braga D, Lackner G. One Ring to Fight Them All: The Sulfazecin Story. Cell Chem Biol. 2017 Jan 19;24(1):1-2. doi: 10.1016/j.chembiol.2017.01.001. PubMed PMID: 28107651.
4: Li R, Oliver RA, Townsend CA. Identification and Characterization of the Sulfazecin Monobactam Biosynthetic Gene Cluster. Cell Chem Biol. 2017 Jan 19;24(1):24-34. doi: 10.1016/j.chembiol.2016.11.010. Epub 2016 Dec 22. PubMed PMID: 28017601; PubMed Central PMCID: PMC5286544.
5: Box SJ, Brown AG, Gilpin ML, Gwynn MN, Spear SR. MM 42842, a new member of the monobactam family produced by Pseudomonas cocovenenans. II. Production, isolation and properties of MM 42842. J Antibiot (Tokyo). 1988 Jan;41(1):7-12. PubMed PMID: 3346195.
6: Parker WL, O'Sullivan J, Sykes RB. Naturally occurring monobactams. Adv Appl Microbiol. 1986;31:181-205. Review. PubMed PMID: 3521210.
7: Okonogi K, Sugiura A, Kuno M, Ono H, Harada S, Higashide E. Interactions of formylamino- and methoxy-substituted beta-lactam antibiotics with beta-lactamases. J Antibiot (Tokyo). 1985 Nov;38(11):1555-63. PubMed PMID: 3878359.
8: Imada A, Kondo M, Okonogi K, Yukishige K, Kuno M. In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic. Antimicrob Agents Chemother. 1985 May;27(5):821-7. PubMed PMID: 3874598; PubMed Central PMCID: PMC180159.
9: Sendai M, Hashiguchi S, Tomimoto M, Kishimoto S, Matsuo T, Kondo M, Ochiai M. Chemical modification of sulfazecin. Synthesis of 4-(substituted methyl)-2-azetidinone-1-sulfonic acid derivatives. J Antibiot (Tokyo). 1985 Mar;38(3):346-71. PubMed PMID: 4008329.
10: Kishimoto S, Sendai M, Tomimoto M, Hashiguchi S, Matsuo T, Ochiai M. Chemical modification of sulfazecin. Synthesis of 4-methoxycarbonyl-2-azetidinone-1-sulfonic acid derivatives. Chem Pharm Bull (Tokyo). 1984 Jul;32(7):2646-59. PubMed PMID: 6499083.
11: Kishimoto S, Sendai M, Hashiguchi S, Tomimoto M, Satoh Y, Matsuo T, Kondo M, Ochiai M. Synthesis of sulfazecin-type 2-azetidinones with a carbon substituent at the 4-position. J Antibiot (Tokyo). 1983 Oct;36(10):1421-4. PubMed PMID: 6358173.
12: Imada A, Kintaka K, Nakao M, Shinagawa S. Bulgecin, a bacterial metabolite which in concert with beta-lactam antibiotics causes bulge formation. J Antibiot (Tokyo). 1982 Oct;35(10):1400-3. PubMed PMID: 6757229.
13: Kintaka K, Haibara K, Asai M, Imada A. Isosulfazecin, a new beta-lactam antibiotic, produced by an acidophilic pseudomonad. Fermentation, isolation and characterization. J Antibiot (Tokyo). 1981 Sep;34(9):1081-9. PubMed PMID: 7328050.
14: Asai M, Haibara K, Muroi M, Kintaka K, Kishi T. Sulfazecin, a novel beta-lactam antibiotic of bacterial origin. Isolation and chemical characterization. J Antibiot (Tokyo). 1981 Jun;34(6):621-7. PubMed PMID: 7024230.
15: Imada A, Kitano K, Kintaka K, Muroi M, Asai M. Sulfazecin and isosulfazecin, novel beta-lactam antibiotics of bacterial origin. Nature. 1981 Feb 12;289(5798):590-1. PubMed PMID: 7007891.